Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis

Cerebrospinal fluid proteomics in multiple sclerosis

(2015) Ann C. Kroksveen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

(2015) Ester Cantó et al.   BRAIN

Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis

(2015) G Hinsinger et al.   Multiple Sclerosis Journal

Evidence in chronic fatigue syndrome for severity-dependent upregulation of prefrontal myelination that is independent of anxiety and depression

(2015) Leighton R. Barnden et al.   NMR IN BIOMEDICINE

Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis

(2015) G Hinsinger et al.   Multiple Sclerosis Journal

A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility

(2014) V Damotte et al.   GENES AND IMMUNITY

Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET Study

(2014) Y. Nakatomi et al.   JOURNAL OF NUCLEAR MEDICINE

Effects of Blood Contamination and the Rostro-Caudal Gradient on the Human Cerebrospinal Fluid Proteome

(2014) Elise Aasebø et al.   PLoS One

Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration

(2014) Maria Liguori et al.   PLoS One

Diverse pathological implications of YKL-40: Answers may lie in ‘outside-in’ signaling

(2013) Mansi Prakash et al.   CELLULAR SIGNALLING

Effects of Natalizumab Treatment on the Cerebrospinal Fluid Proteome of Multiple Sclerosis Patients

(2013) Marcel P. Stoop et al.   JOURNAL OF PROTEOME RESEARCH

Body fluid biomarkers in multiple sclerosis

(2013) Manuel Comabella et al.   LANCET NEUROLOGY

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

(2013) Charlotte Teunissen et al.   Multiple Sclerosis Journal

Gray Matter Is Targeted in First-Attack Multiple Sclerosis

(2013) Steven E. Schutzer et al.   PLoS One

Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls

(2012) A. C. Kroksveen et al.   ACTA NEUROLOGICA SCANDINAVICA

The influence of ageing in the cerebrospinal fluid concentrations of proteins that are derived from the choroid plexus, brain, and plasma

(2012) Carl P.C. Chen et al.   EXPERIMENTAL GERONTOLOGY

Proteomic Analysis of Cerebrospinal Fluid in a Fulminant Case of Multiple Sclerosis

(2012) Judit Füvesi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM

(2012) Ann C. Kroksveen et al.   Journal of Proteomics

Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis

(2011) Ajit Singh Dhaunchak et al.   ANNALS OF NEUROLOGY

Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury

(2011) Chun Geun Lee et al.   Annual Review of Physiology

Differential expression of complement proteins in cerebrospinal fluid from active multiple sclerosis patients

(2011) Yun Li et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis

(2010) Manuel Comabella et al.   BRAIN

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

(2010) Jan Ottervald et al.   Journal of Proteomics

Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics

(2010) A.C. Kroksveen et al.   Journal of Proteomics

Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis

(2010) Violaine K. Harris et al.   NEUROBIOLOGY OF DISEASE

Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis

(2010) Marcel P. Stoop et al.   PLoS One

Accurate and Sensitive Peptide Identification with Mascot Percolator

(2009) Markus Brosch et al.   JOURNAL OF PROTEOME RESEARCH

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

(2008) Jürgen Cox et al.   NATURE BIOTECHNOLOGY